Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Jeannie Brant, PhD, APRN, AOCN, FAAN, on innovations that support the integration of palliative care

Dr. Brant, Oncology Clinical Nurse Specialist, Pain Consultant Specialist, Billings Cancer Center, elaborates on the innovations that must be made to successfully integrate palliative care into outpatient oncology

Published: 30 October 2017

Recent Videos: ASCO Palliative and Supportive Care Conference Coverage

video

Charles Loprinzi, MD, on the importance of physician communication in making an end of life plan

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, describes the importance of physician communication ...

video

Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapies

Dr. Patel, Assistant Professor of Medicine, Deputy Director, San Diego Center for Precision Immunotherapy, Co-Leader, Experimental Therapeutics (Phase 1), UC ...

video

Jeannie Brant, PhD, APRN, AOCN, FAAN, on innovations that support the integration of palliative care

Dr. Brant, Oncology Clinical Nurse Specialist, Pain Consultant Specialist, Billings Cancer Center, elaborates on the innovations that must be made ...

video

Charles Loprinzi, MD, considers the best approach to preventing nausea during chemotherapy

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, elaborates on the best approach to ...

video

Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of life

Dr. Patel, Assistant Professor of Medicine, Deputy Director, San Diego Center for Precision Immunotherapy, Co-Leader, Experimental Therapeutics (Phase 1), UC ...

video

Jeannie Brant, PhD, APRN, AOCN, FAAN, discusses integrating palliative care in cancer centers

Dr. Brant, Oncology Clinical Nurse Specialist, Pain Consultant Specialist, Billings Cancer Center, considers the critical success factors when integrating palliative ...

video

Charles Loprinzi, MD, discusses managing nasal vestibulitis during cancer treatment

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, provides insight into the management of ...

video

Sharon Bober, PhD, describes how treating sexual dysfunction fits into a symptom management plan

Dr. Bober, Founder & Director, Sexual Health Program Senior Psychologist, Dana-Farber Cancer Institute, offers opinion on how preventing and treating ...

video

Jeannie Brant, PhD, APRN, AOCN, FAAN, on incorporating palliative care at Billings Cancer Center

Dr. Brant, Oncology Clinical Nurse Specialist, Pain Consultant Specialist, Billings Cancer Center, describes the experience of integrating palliative care at ...

video

Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

Dr. Loprinzi, Regis Professor of Breast Cancer Research, Division of Medical Oncology, Mayo Clinic, elaborates on the role of supportive ...

Related Videos

video-image

Charles Loprinzi, MD, on the importance of physician communication in making an end of life plan

video-image

Charles Loprinzi, MD, considers the best approach to preventing nausea during chemotherapy

video-image

Charles Loprinzi, MD, discusses managing nasal vestibulitis during cancer treatment

video-image

Charles Loprinzi, MD, explains the role of palliative and supportive care in medical oncology

video-image

Erin Stevens, MD, on how treating sexual dysfunction fits into a symptom management plan

video-image

Erin Stevens, MD, elaborates on interventions to address sexual dysfunction in cancer patients

video-image

Erin Stevens, MD, on why oncologists should be concerned about sexual health in their patients

video-image

Erin Stevens, MD, considers the prevalence of sexual dysfunction in advanced cancer patients

video-image

Sandip Patel, MD, discusses some solutions for managing toxicities associated with immunotherapies

video-image

Sandip Patel, MD, considers immunotherapy combinations and the likelihood of severe adverse events

video-image

Sandip Patel, MD, on identifying patient types likely to experience immune-related adverse events

video-image

Sandip Patel, MD, describes the prominent safety challenges with administration of immunotherapies

video-image

Sandip Patel, MD, on the role of immunotherapies when treating cancer near end of life

video-image

Sharon Bober, PhD, describes how treating sexual dysfunction fits into a symptom management plan

video-image

Sharon Bober, PhD, considers intervention methods to address sexual dysfunction in cancer patients

video-image

Sharon Bober, PhD, explains how sexual health fits into quality of life in patient-reported outcomes

video-image

Sharon Bober, PhD, elaborates on the prevalence of sexual dysfunction in advanced cancer patients

video-image

Timothy Morgenthaler, MD, on what drugs seem to be most effective when treating insomnia

video-image

Timothy Morgenthaler, MD, discusses prevention of insomnia in susceptible advanced cancer patients

video-image

Timothy Morgenthaler, MD, regarding the prevalence of insomnia when treating advanced cancer

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, on the role of a medical home and palliative care

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, on how palliative care looks in a rural practice setting

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, discusses integrating palliative care in cancer centers

video-image

Jeannie Brant, PhD, APRN, AOCN, FAAN, on incorporating palliative care at Billings Cancer Center

video-image

Rudolph Navari, MD, considers how treating nausea fits into a broader symptom management plan

video-image

Rudolph Navari, MD, regarding effective drugs or drug regimens when treating CINV in advanced cancer

video-image

Rudolph Navari, MD, on identifying advanced cancer patients more likely to experience severe nausea

video-image

Rudolph Navari, MD, describes the prevalence of nausea when treating advanced cancer

video-image

Ulka N. Vaishampayan, MD, on challenges facing patients and providers

video-image

Ana Aparicio, MD, explains data and conclusions from her presentation at ASCO GU 2017

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, on treating metastatic prostate cancer with multiple drugs

video-image

Robert B. Den, MD, give his thoughts on the most intriguing research presented at ASCO GU

video-image

Jeffrey M. Holzbeierlein, MD, highlights the most promising data coming out of ASCO GU 2017

video-image

Neal D. Shore, MD, FACS, provides insight into data on resistance and advanced prostate cancer

video-image

Ana Aparicio, MD, on how to sequence commonly used agents in metastatic prostate cancer

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, discusses resistance and advanced prostate cancer

video-image

Robert B. Den, MD, discusses the recent changes in radiation treatment for invasive bladder cancer

video-image

David J. McConkey, PhD, on which drugs have the highest potential to impact bladder cancer treatment

video-image

Mohamad E. Allaf, MD, on immunotherapies and renal cell carcinoma treatment algorithms

video-image

Jeffrey M. Holzbeierlein, MD, offers his opinion on interesting presentations from ASCO GU 2017

video-image

Neal D. Shore, MD, FACS, explains the impact of CHAARTED and STAMPEDE

video-image

Matthew I. Milowsky, MD, outlines treating bladder cancer with checkpoint inhibitors

video-image

Eric Jonasch, MD, on integrating immunotherapies into renal cell carcinoma treatment algorithms

video-image

Ana Aparicio, MD, on immunotherapy as a future treatment guideline for metastatic prostate cancer

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, on immunotherapy and metastatic prostate cancer

video-image

Freddie C. Hamdy, MD, offers his opinion on exciting research from ASCO GU 2017

video-image

David J. McConkey, PhD, on treating bladder cancer with checkpoint inhibitors

video-image

Mohamad E. Allaf, MD, provides insight into treating metastatic non-clear cell renal cell carcinoma

video-image

Ulka N. Vaishampayan, MD, on immunotherapies and renal cell carcinoma treatment algorithms

video-image

Jeffrey M. Holzbeierlein, MD, gives his perspective on treatment trends in urology for 2017

video-image

Neal D. Shore, MD, FACS, on where chemotherapy fits into prostate cancer treatment

video-image

Alexandra Drakaki, MD, PhD, shares highlights from sessions in bladder cancer at ASCO GU 2017

video-image

Matthew I. Milowsky, MD, explains how genomics are changing the way we treat bladder cancer subtypes

video-image

Eric Jonasch, MD, on targeted therapies used to treat non-clear cell renal cell carcinoma

video-image

Aly-Khan Lalani, MD, shares the results of his ASCO GU 2017 poster session

video-image

Ana Aparicio, MD, on commercial AR-V7 tests and metastatic castrate-resistant prostate cancer

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, explains the influence of CHAARTED and STAMPEDE

video-image

Robert B. Den, MD, on which patients with low-risk prostate cancer should receive radiation

video-image

Freddie C. Hamdy, MD, on putting into practice what we’ve learned from the ProtecT study

video-image

David J. McConkey, PhD, provides information on treating bladder cancer with checkpoint inhibitors

video-image

Mohamad E. Allaf, MD, shares the most intriguing research presented at ASCO GU 2017

video-image

Eric Jonasch, MD, on approaches to consider with metastatic non-clear renal cell carcinoma

video-image

Aly-Khan Lalani, MD, offers feedback on using immunotherapies to treat renal cell carcinoma patients

video-image

Ana Aparicio, MD, discusses where chemotherapy fits in regard to prostate cancer treatment

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, on BRCA1 and BRCA2 genetic testing as guidelines

video-image

Robert B. Den, MD, on the QOL differences between clinically localized prostate cancer patients

video-image

Freddie C. Hamdy, MD, elaborates on factors from the ProtecT study

video-image

David J. McConkey, PhD, on non-invasive imaging and monitoring metastatic bladder cancer

video-image

Mohamad E. Allaf, MD, on helping non-metastatic renal cell carcinoma patients with adjuvant therapy

video-image

Ulka N. Vaishampayan, MD, on metastatic renal cell carcinoma patients and chemotherapy

video-image

Jeffrey M. Holzbeierlein, MD, on the impact of his data presented at ASCO GU 2017

video-image

Neal D. Shore, MD, FACS, on metastatic castration-resistant prostate cancer patients

video-image

Alexandra Drakaki, MD, PhD, on what we need to know about checkpoint inhibitors and bladder cancer

video-image

Matthew I. Milowsky, MD, on the role of genomics in understanding heterogeneity in bladder cancer

video-image

Eric Jonasch, MD, on treating non-metastatic renal cell carcinoma patients with adjuvant therapy

video-image

Aly-Khan Lalani, MD, examines the integration of immunotherapies for renal cell carcinoma treatment

video-image

Ana Aparicio, MD, discusses the impact of CHAARTED and STAMPEDE on her treatment decisions

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, on metastatic castration-resistant prostate cancer patients

video-image

Robert B. Den, MD, on the recent adoption of radiation treatment for advanced prostate cancer

video-image

Freddie C. Hamdy, MD, informs us on the ProtecT study top line results

video-image

David J. McConkey, PhD, on the responses to immunotherapy for varied bladder cancer subtypes

video-image

David J. McConkey, PhD, on the influence of genomics for the treatment of bladder cancer subtypes

video-image

Mohamad E. Allaf, MD, on non-metastatic renal cell cancer patients and adjuvant therapy

video-image

Ulka N. Vaishampayan, MD, provides her opinion on the most interesting research at ASCO GU 2017

video-image

Nicholas J. Vogelzang, MD, FASCO, FACP, discusses the influence of an AR-V7 commercial test

video-image

Neal D. Shore, MD, FACS, on the impact of an AR-V7 commercial test

video-image

Jeffrey M. Holzbeierlein, MD, summarizes data and conclusions from his presentation at ASCO GU 2017

video-image

Neal D. Shore, MD, FACS, on BRCA1 and BRCA2 genetic testing as guidelines for prostate cancer

video-image

Alexandra Drakaki, MD, PhD, describes her work with microRNA and the potential clinical implications

video-image

Matthew I. Milowsky, MD, shares highlights from his lecture on urothelial carcinoma

video-image

Eric Jonasch, MD, on which non-metastatic renal cell cancer patients should receive adjuvant therapy

video-image

Aly-Khan Lalani, MD, provides feedback on which ASCO GU research presentations were most intriguing

video-image

Ana Aparicio, MD, on metastatic castration-resistant prostate cancer patients and chemotherapy

video-image

Robert B. Den, MD, considers topics in the “Best of Journals: Prostate Cancer” panel discussion

video-image

Freddie C. Hamdy, MD, on how the design of the ProtecT study works

video-image

David J. McConkey, PhD, discusses how genomics helps us understand heterogeneity in bladder cancer

video-image

Nicholas J. Vogelzang, MD, on where chemotherapy fits into treatment for prostate cancer

video-image

Daniel Petrylak, MD, offers recommendations for bladder cancer patients

video-image

Miriam Yvette Jones Atkins, MD, explains how the COA Patient Advocacy Network makes a difference

video-image

Miriam Yvette Jones Atkins, MD, on involving patients in the COA Patient Advocacy Network

video-image

Miriam Yvette Jones Atkins, MD, on how the COA Patient Advocacy Network benefits patients

video-image

Skip Burris, MD, offers his opinion on molecular profiling patients

video-image

William Harwin, MD, describes the shift from fee for service to value-based care

video-image

Steve D’Amato, R.Ph., explains how his practice helps patients get access to cancer care